CG
AERI

Cutler Group’s Aerie Pharmaceuticals AERI Stock Holding History

Cutler Group’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,100
Closed -$32K – 4981
2018
Q4 		$32K Hold
6,100
– – ﹤0.01% 1776
2018
Q3 		$5K Sell
6,100
-10,000
-62% -$643K ﹤0.01% 3103
2018
Q2 		$11K Buy
16,100
+8,700
+118% +$487K ﹤0.01% 2640
2018
Q1 		$20K Sell
7,400
-12,200
-62% -$682K ﹤0.01% 2307
2017
Q4 		$100K Hold
19,600
– – ﹤0.01% 1374
2017
Q3 		$102K Sell
19,600
-11,800
-38% -$644K ﹤0.01% 1663
2017
Q2 		$41K Buy
31,400
+19,500
+164% +$908K ﹤0.01% 2704
2017
Q1 		$36K Sell
11,900
-42,000
-78% -$1.87M ﹤0.01% 2728
2016
Q4 		$125K Sell
53,900
-24,100
-31% -$911K ﹤0.01% 1708
2016
Q3 		$97K Buy
78,000
+77,100
+8,567% +$1.7M ﹤0.01% 1843
2016
Q2 		$1K Sell
900
-100
-10% -$1.62K ﹤0.01% 6370
2016
Q1 		$2K Sell
1,000
-1,800
-64% -$28.5K ﹤0.01% 5736
2015
Q4 		$5K Buy
+2,800
New +$65.3K ﹤0.01% 4971

Cutler Group's AERI Position: Q4 2022 in Review

Cutler Group sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 2,000 shares — an estimated $30K sold.

Cutler Group first reported a position in AERI in Q4 2015 and held it in 23 quarters. The position peaked at $903K in Q3 2016. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Cutler Group reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 2,000 Aerie Pharmaceuticals shares in Q4 2022, an estimated $30K.
  • Cutler Group first reported a position in Aerie Pharmaceuticals in Q4 2015 and held it in 23 quarters.
  • Cutler Group's Aerie Pharmaceuticals position peaked at $903K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.